Dr. Bhadresh Shah, M.D.
What this data tells you about Dr. Shah
Dr. Bhadresh Shah is a pulmonary disease in Sugar Land, TX, with 20 years in practice. Based on federal Medicare data, Dr. Shah performed 5,315 Medicare services across 3,829 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $5,407 from 29 pharmaceutical and/or device companies across 201 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,125 | $92 | $236 |
| Office visit, established patient (20-29 min) | 958 | $65 | $159 |
| Test to examine how well the lungs exchange gases | 432 | $40 | $175 |
| Test to determine lung volumes using sensors | 423 | $40 | $176 |
| Hospital follow-up visit, moderate complexity | 393 | $61 | $158 |
| Hospital follow-up visit, high complexity | 328 | $91 | $226 |
| Test to measure rate of airflow | 237 | $29 | $89 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 203 | $29 | $138 |
| Flu vaccine administration | 164 | $30 | $67 |
| Flu vaccine, high-dose | 162 | $71 | $77 |
| New patient office visit (30-44 min) | 143 | $78 | $238 |
| Initial hospital admission, high complexity | 125 | $132 | $441 |
| New patient office visit (45-59 min) | 106 | $120 | $363 |
| Drug injection, under skin or into muscle | 92 | $11 | $55 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 90 | $480 | $1,903 |
| Sleep study in sleep lab (6 years or older) | 84 | $455 | $1,728 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 68 | $4 | $15 |
| Pneumonia vaccine administration | 46 | $29 | $55 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 44 | $276 | $594 |
| Office visit, established patient, complex (40-54 min) | 29 | $137 | $316 |
| Critical care, first 30-74 min | 28 | $163 | $603 |
| Initial hospital admission, moderate complexity | 24 | $100 | $301 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 11 | $0 | $1 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (44%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Shah is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), and consulting-driven industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with office visit, established patient (30-39 min)?
Does Dr. Shah receive payments from pharmaceutical companies?
How do Dr. Shah's costs compare to other pulmonary diseases in Sugar Land?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology